OA11480A - 6,9-Disubstituted 2Ätrans-(4-aminocyclohexy)aminoÜpurines. - Google Patents

6,9-Disubstituted 2Ätrans-(4-aminocyclohexy)aminoÜpurines. Download PDF

Info

Publication number
OA11480A
OA11480A OA1200000234A OA1200000234A OA11480A OA 11480 A OA11480 A OA 11480A OA 1200000234 A OA1200000234 A OA 1200000234A OA 1200000234 A OA1200000234 A OA 1200000234A OA 11480 A OA11480 A OA 11480A
Authority
OA
OAPI
Prior art keywords
amino
trans
aminocyclohexyl
cyclopentylpurine
compound according
Prior art date
Application number
OA1200000234A
Other languages
English (en)
Inventor
Alan J Bitonti
Dvid R Borcherding
Jennifer A Dumont
Munson H Randall
Norton P Peet
Patrick W K Shum
Original Assignee
Aventic Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventic Pharmaceuticals Inc filed Critical Aventic Pharmaceuticals Inc
Publication of OA11480A publication Critical patent/OA11480A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200000234A 1998-02-26 2000-08-25 6,9-Disubstituted 2Ätrans-(4-aminocyclohexy)aminoÜpurines. OA11480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26

Publications (1)

Publication Number Publication Date
OA11480A true OA11480A (en) 2004-05-05

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000234A OA11480A (en) 1998-02-26 2000-08-25 6,9-Disubstituted 2Ätrans-(4-aminocyclohexy)aminoÜpurines.

Country Status (31)

Country Link
EP (1) EP1056745B1 (fr)
JP (1) JP2002504553A (fr)
KR (1) KR100568658B1 (fr)
CN (1) CN1128149C (fr)
AP (1) AP1258A (fr)
AR (1) AR019822A1 (fr)
AT (1) ATE269332T1 (fr)
AU (1) AU748178B2 (fr)
BR (1) BR9908325A (fr)
CA (1) CA2320448C (fr)
CZ (1) CZ291604B6 (fr)
DE (1) DE69918062T2 (fr)
DK (1) DK1056745T3 (fr)
EE (1) EE04315B1 (fr)
ES (1) ES2219038T3 (fr)
HK (1) HK1030948A1 (fr)
HU (1) HUP0100931A3 (fr)
IL (2) IL138044A0 (fr)
NO (1) NO20004281L (fr)
NZ (1) NZ506234A (fr)
OA (1) OA11480A (fr)
PL (1) PL344021A1 (fr)
PT (1) PT1056745E (fr)
RU (1) RU2191777C2 (fr)
SI (1) SI1056745T1 (fr)
SK (1) SK12912000A3 (fr)
TR (1) TR200002482T2 (fr)
TW (1) TW541308B (fr)
UA (1) UA62996C2 (fr)
WO (1) WO1999043676A2 (fr)
ZA (1) ZA991548B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
US6627633B2 (en) * 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
CZ20022353A3 (cs) * 2000-01-07 2003-02-12 Universitaire Instelling Antwerpen Deriváty purinu, způsob jejich přípravy a jejich použití
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
EP1274706A1 (fr) 2000-04-18 2003-01-15 Agouron Pharmaceuticals, Inc. Pyrazoles permettant d'inhiber des proteines kinases
MXPA03001189A (es) 2000-08-09 2004-05-14 Agouron Pharma Compuestos de pirazol-tiazol, composiciones farmaceuticas que los contienen y su uso para inhibir las cinasas dependientes de ciclinas.
DE60110802T2 (de) 2000-08-18 2005-10-06 Agouron Pharmaceuticals, Inc., San Diego Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
DE60138140D1 (de) * 2000-10-31 2009-05-07 Aventis Pharma Inc Acyl- und sulfonylderivative 6,9-disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
DE60205376T2 (de) 2001-06-27 2006-04-06 Cyclacel Ltd. 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
US20060135445A1 (en) * 2003-02-04 2006-06-22 Kabushiki Kaisha Yakult Honsha Breast cancer-resistant protein inhibitor
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
SG170819A1 (en) * 2006-03-30 2011-05-30 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
RU2681081C2 (ru) * 2007-10-05 2019-03-04 Верастэм, Инк. Пиримидинзамещенные производные пурина, фармацевтическая композиция на их основе, способ ингибирования протеинкиназ, способ лечения или профилактики заболеваний, чувствительных к ингибированию протеинкиназ, и способ лечения пролиферативных заболеваний
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
WO2013130461A1 (fr) 2012-02-29 2013-09-06 The Scripps Research Institute Inhibiteurs de dégradation de wee1
JPWO2015005491A1 (ja) * 2013-07-12 2017-03-02 国立大学法人京都大学 疾病の発症又は進行の一因となる異常スプライシングを抑制できる物質のスクリーニング方法
DK3244891T3 (da) 2015-01-16 2022-10-24 Massachusetts Gen Hospital Forbindelser til forbedring af mrna-splejsning
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
EP3997089A4 (fr) * 2019-07-21 2023-08-16 University Of Virginia Patent Foundation Compositions de liaison à la cystéine et leurs procédés d'utilisation
WO2024105159A1 (fr) * 2022-11-16 2024-05-23 University Of Zurich Ligands des lecteurs d'arn m6a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
US7091346B1 (en) * 1995-11-01 2006-08-15 Novartis Ag Purine derivatives and processes for their preparation
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
DK1056745T3 (da) 2004-10-25
KR100568658B1 (ko) 2006-04-07
HUP0100931A3 (en) 2002-08-28
AP2000001923A0 (en) 2000-09-30
IL138044A0 (en) 2001-10-31
ZA991548B (en) 1999-08-26
HUP0100931A2 (hu) 2002-04-29
EP1056745B1 (fr) 2004-06-16
EP1056745A2 (fr) 2000-12-06
SI1056745T1 (en) 2004-12-31
TR200002482T2 (tr) 2002-10-21
RU2191777C2 (ru) 2002-10-27
SK12912000A3 (sk) 2001-08-06
CZ20003106A3 (cs) 2000-12-13
CA2320448C (fr) 2005-02-01
HK1030948A1 (en) 2001-05-25
PT1056745E (pt) 2004-09-30
EE200000501A (et) 2002-02-15
BR9908325A (pt) 2000-11-07
AU748178B2 (en) 2002-05-30
CN1128149C (zh) 2003-11-19
NO20004281L (no) 2000-10-18
AR019822A1 (es) 2002-03-20
AP1258A (en) 2004-03-15
IL138044A (en) 2006-04-10
JP2002504553A (ja) 2002-02-12
AU3299099A (en) 1999-09-15
TW541308B (en) 2003-07-11
NO20004281D0 (no) 2000-08-25
NZ506234A (en) 2003-05-30
WO1999043676A2 (fr) 1999-09-02
KR20010041315A (ko) 2001-05-15
CA2320448A1 (fr) 1999-09-02
DE69918062D1 (de) 2004-07-22
CN1291983A (zh) 2001-04-18
DE69918062T2 (de) 2005-06-02
PL344021A1 (en) 2001-09-24
CZ291604B6 (cs) 2003-04-16
UA62996C2 (en) 2004-01-15
EE04315B1 (et) 2004-06-15
ES2219038T3 (es) 2004-11-16
WO1999043676A3 (fr) 1999-10-21
ATE269332T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
US6413974B1 (en) 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
OA11480A (en) 6,9-Disubstituted 2Ätrans-(4-aminocyclohexy)aminoÜpurines.
US6479487B1 (en) 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
EP1377579B1 (fr) Derives acyle et sulfonyle de 2-(trans-1,4-diaminocyclohexyl)-purines 6,9-disubstitu es et leur utilisation comme antiprolif rants
AU2002239388A1 (en) Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US7429595B2 (en) Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6642231B2 (en) 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
MXPA00008376A (en) 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines
ES2207182T3 (es) 2-(trans-(4- aminociclohexil) amino) purinas 6,9-disustituidas.
CZ20003104A3 (cs) 6,9-Disubstituované 2-[trans-(4- aminocyklohexyl)amino]-puriny, farmaceutické prostředky obsahující tyto sloučeniny a použití
MXPA00008377A (en) 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines
ZA200303299B (en) Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents.